J
Joseph J. Eron
Researcher at University of North Carolina at Chapel Hill
Publications - 569
Citations - 49427
Joseph J. Eron is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Viral load & Population. The author has an hindex of 99, co-authored 511 publications receiving 44857 citations. Previous affiliations of Joseph J. Eron include Duke University.
Papers
More filters
Journal ArticleDOI
CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection
Marc A. Frahm,Ralph A. Picking,Jo Ann D. Kuruc,Kara S. McGee,Joseph J. Eron,Charles B. Hicks,Georgia D. Tomaras,Guido Ferrari +7 more
TL;DR: DP T cells represent a highly reactive cell population during acute HIV infection, which responds independently from the traditional T cell compartments, and the presence of proliferating DP T cells following all HIV Ag stimulations is well correlated with proliferating CD4 T cells whereas multifunctionality appears to be largely independent of multifunctional in other T cellcompartments.
Journal ArticleDOI
Reductions in Hiv-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials
Schlomo Staszewski,Andrew M. Hill,John Bartlett,Joseph J. Eron,Christine Katlama,Judy Johnson,W. Sawyer,Hugh McDade +7 more
TL;DR: ZDV/3TC combination treatment delays the progression of CDC B/C disease compared with control treatments and is seen in subgroups of naive and pre-treated patients, those with high and low CD4 counts and symptomatic and asymptomatic patients.
Journal ArticleDOI
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.
Ralph DeMasi,Neil M.H. Graham,Jerry M. Tolson,Sissi V. Pham,George A. Capuano,Robin L. Fisher,Mark S. Shaefer,Gary E. Pakes,Gosford A. Sawyerr,Joseph J. Eron +9 more
TL;DR: Self-reported adherence derived from the Patient Medication Adherence Questionnaire Version 1.0 predicted virologic outcomes, but further refinement of the dimensions appears warranted.
Journal ArticleDOI
Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients.
Elizabeth L. Yanik,Sonia Napravnik,Christopher B. Hurt,Ann M Dennis,E. Byrd Quinlivan,Joe Sebastian,Joann D. Kuruc,Joseph J. Eron +7 more
TL;DR: AHI patients may represent a vanguard group that portends increasing TDR in the future, and other predictors with transmitted drug resistance (TDR) prevalence were assessed in a cohort of HIV-infected, antiretroviral-naïve patients.
Journal ArticleDOI
Perceived Oral Health Status, Unmet Needs, and Barriers to Dental Care Among HIV/AIDS Patients in a North Carolina Cohort: Impacts of Race
TL;DR: Disparities exist within this HIV-infected population in oral symptoms, utilization patterns, and perceived unmet dental need, and targeted interventions that address barriers to care are needed to help establish preventive dental care patterns in this region, especially among blacks.